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ABSTRACT  
Purpose: The aim of this study was to identify the  knowledge and awareness about human papilloma virus (HPV) and 
human papilloma virus (HPV) vaccine of women in reproductive age.  
Material and Methods: The study covered 294 women aged between 15 and 49. A questionnaire was prepared by the 
researchers based on the literature review.  
Results: The mean age of the participants was 30.5±8.9 years. Only 24.5% had heard about HPV infection and 28.2% 
had heard HPV vaccine. Of the participants, 188 (63.9%) got zero point from the knowledge questions.  
Conclusion: This study indicates that the women who apply primary care units have low knowledge levels; it is 
apperent that personal and social education is needed. Paying importance to patient education on HPV and cervical 
cancer in primary care health politics will increase knowledge and awareness for HPV infection and HPV vaccination. 
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ÖZET 
Amaç: Bu çalışmanın amacı doğurganlık çağındaki kadınların HPV ve HPV aşısı hakkındaki farkındalık ve bilgi 
düzeylerini ortaya çıkarmaktır.  
Materyal ve Metod: Çalışmaya 15-49 yaş aralığındaki 294 kadın dahil edildi. Yazarlar tarafından literatür taranarak 
hazırlanan anket formunun doldurulması istendi.  
Bulgular: Katılımcıların ortalama yaşı 30.5±8.9 idi. Yalnızca %24.5'i HPV enfeksiyonundan, %28.2'si ise HPV aşısından 
haberdardı. Katılımcılardan 188'i  bilgi sorularından sıfır puan aldı.  
Sonuç: Bu çalışma birinci basamağa başvuran kadınların düşük bilgi düzeyinde olduklarını , bireysel ve toplumsal 
eğitimin gerekliliğini göstermiştir. Birinci basamak sağlık politikalarında hasta eğitimine önem verilmesi toplumun bilgi ve 
farkındalık düzeylerini artıracak ve kanser insidansının düşmesini sağlayacaktır. 
Anahtar kelimeler: HPV, HPV aşısı, Birinci Basamak, Bilgi Düzeyi 
INTRODUCTION 
 As well as being the second cancer type that 
is the most common among women in the world,  
 
 
cervical cancer is the second most common 
reason for the cancer deaths
1-4
. According to the 
data revealed by Turkish Ministry of Health, while 
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cervical cancer incidence rate was 0.7/100000 in 
1996, it increased up to 3.87/100000 in 2007
5
. 
 Human papilloma virus (HPV) is the viral 
infection that is the most common sexually 
transmitted and it is responsible for approximately 
90% of cases of  invasive cervical cancer
6-8
. It was 
demonstrated that the well organised screening 
programmes influentially decreases disease 
incidence and mortality
9
. In the studies, it was 
indicated that getting vaccinated against HPV 16 
and 18 infections can enable protection against 
invasive cervical cancer at the rate of 70%
6
. It was 
also observed that HPV vaccine acceptability 
increased when the groups that were under risk 
were instructed  about HPV and its related disease 
the knowledge level about HPV and HPV vaccine 
acceptability increased
10
.  
 In most studies, HPV prevalance and 
frequency of HPV types which have a great 
potential for cervical cancer like HPV type 16 is 
high in our country contrary to what is often 
supposed. Also, frequency of risk behavior is high 
in terms of servical cancer such as early sexual 
intercouse, sexual partners more than one
4,11-13
. 
Therefore, increasing level of knowledge about 
HPV and HPV vaccine has a great importance to 
battle against cervical cancer. 
 In this study we aimed to identify the 
knowledge level in a group of women who are 
between the ages of 15 and 49, the age group 
accepted as in era of fertility and under the risk of 
HPV infection.  
MATERİAL AND METHODS 
 This cross sectional study was conducted in 
five primary care centres during six months period. 
Each center serves to populations that have similar 
socio-cultural features. All of the centers were 
under administration of Dışkapı Yıldırım Beyazıt 
Teaching and Research Hospital, Ankara. 
 The women who were volunteer between the 
ages of 15 and 49 that present to the outpatient 
unit with any complaints other than gynaecological 
related symptoms and/or HPV vaccine demand 
were informed about the study and their oral 
consent was obtained. The patients who are 
illiterate, have communication disabilities, are with 
severe visual or hearing impairments to fill out 
questionnaire were not included in the study. 
 Participants were asked to fill out socio-
demographic data form that include questions 
about their ages, marital status, age at first 
marriage, duration of last marriage, number of 
children, number of miscarriage and abortion, 
smoking status, age at first birth, level of education 
of themselves and of their parents, centers which 
are frequently used to get healthcare. They were 
asked if they ever heard about HPV and HPV 
vaccine. Afterwards, they were asked to give 
answers for 9 statements like “True”, “False” or “ I 
don’t know” that measure their level of knowledge 
about HPV and HPV vaccine, which was prepared 
by the researchers in the light of literature review. 
The participants had 1 point for each statement 
answered correctly. In case that all statements 
were answered correctly, they had 9 points.  
 The participants were requested to fill out 
questionnaire in an empty room not including their 
names on the forms, and then asked to put them in 
the closed box where questionnaire forms 
collected.  
 Descriptive statistics (frequency, percentage 
distribution, median±standard deviation), Chi 
Square Test for comparing groups and Dunn test 
for comparison among groups, Mann-Whitney U 
Test for comparison of continuous numerical 
variables were used on the data that was obtained 
from the study. 
RESULTS 
 During the study period, 445 questionnaire 
forms were collected in total. One hundred fifty one 
of the forms had missing items so these forms 
were excluded from the study. Two hundred and 
ninety four participants that met the inclusion 
criteria of the study and wholly filled out the given 
forms were included in the study. The mean age of 
the participants was 30.5±8.9 years. The average 
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age at first marriage was 20.99±4.12 years 
(range:14-36). 
 Among all the participants, 33% were married 
at the age 18 or before . The average age at first 
birth was 22.5±4.3 years. The participant who gave 
the earliest birth was 14 years old and the one who 
gave the latest birth was 36. 16.8% of births were 
given under age 18 and 39.8% were given under 
age 20. Other socio-demographic characteristics 
are demonstrated in Table 1.  
 While 35% of the participants never had 
gynaecological examination; 36.7% of them had a 
dozen examinations.  
 Answers given to questions to measure level 
of knowledge related to HPV and HPV vaccine are 
demonstrated in Table 2. 
 One point was given for each true answer 
from the participants and point average of their 
knowledge related to HPV and HPV vaccine was 
found as 1.31±2.13. Of the participants, 188 
(63.9%) got zero point. 
The factors that effected knowledge scores are 
demonstrated in Table 3. 
 Among participants, 72 (24.5%) heard about 
HPV infection and 83 participants(28.2%) heard 
HPV vaccine. 
 The resources that the participants were 
aware about HPV and HPV vaccine are 
demonstrated in Table 4.  
 Awareness of HPV was significantly 
increasing with level of education, the place where 
health care service was provided and the 
frequency of gynaecological examination (p<0.05). 
  Awareness rate of HPV vaccine was 
meaningfully increasing with level of education and 
the place where health care service was provided 
(p<0.05). 
Table 1. Sociodemographic Characteristics of Participants 
Variable      Percent   (n) 
Marital Status 
    Single 
    Married 
    Divorced 
 
29.6%     (87) 
65.3%   (192) 
  5.1%     (15) 
Years of marriage 
    Not married 
    0-3 years 
    ≥ 4 years 
 
29.6%      (87) 
  9.9%      (30) 
60.5%    (177) 
Number of children 
   0 
   1 
   2 
   3 
   ≥ 4 
 
34.7%    (102) 
18.4%      (54) 
29.2%      (86) 
12.6%      (37) 
  5.1%      (15) 
Number of D&C* or abortus 
   0 
   1 
 
67.3%    (198) 
19.7%      (58) 
   2  
   3 
   ≥4 
  8.2%      (24) 
  3.4%      (10) 
  1.4%        (4) 
Education  
   Primary school 
   High school 
   University 
 
34.4%    (101) 
27.2%      (80) 
38.4%    (113) 
Most frequent source of health care 
   Family Health Center 
   State& Training Hospital 
   Faculty of Medicine 
   Private Hospital/Office 
 
34.0%    (100) 
52.0%    (153) 
  9.5%      (28) 
  4.5%      (13) 
 *D&C: Dilatation and Curettage 
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Table 2. Answers Given to Questions of HPV and HPV Vaccine 
 True False I don’t know 
HPV causes cervical cancer and genital warts. (T) 21.4% 1.4% 77.2% 
HPV transmits sexually. (T) 24.5% 1.4% 74.1% 
Using oral contraceptive pills protects from HPV. (F) 5.4% 10.9% 83.7% 
HPV infection is only seen in women. (F) 11.2% 9.5% 79.3% 
HPV infection is always symptomatic. (F) 13.9% 3.7% 82.4% 
There is a vaccine against HPV. (T) 24.5% 1.0% 74.5% 
HPV vaccine protects from cervical cancer and genital warts. (T) 21.4% 0.3% 78.3% 
HPV vaccine provides life-long protection. (F) 8.8% 3.4% 87.8% 
After the vaccine made side effects like pain and rash in injection area, 
headache can be seen. (T) 
12.2% 1.4% 86.4% 
Table 3. Association Between Knowledge Scores And Classificatory Variables. 
*Group with significantly higher levels of knowledge   
 
 
 
 
 
 
 
 
 n X2 Value P Value 
Education    
Elementary  101 36,038 ,000 
High School 80 
University* 113 
Frequency of Gynaecologic Follow-Ups 
At least once in three years* 108 6,530 ,038 
Rare 73 
None 113 
Type of Mostly used Medical centre  
Primary Care Physician 100 13,678 ,003 
State & Training Hospital 153 
Faculty of Medicine* 28 
Private Hospital/Office 13 
Years Of Marriage 
Not Married 88 3,15 ,207 
0-3 years 29 
≥4 years 177 
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Table 4. Awareness sources of HPV and HPV vaccine 
 HPV HPV Vaccine 
Healthcare staff 72.2% 53.0% 
Television 37.5% 50.6% 
Internet 31.9% 30.1% 
Friends/ Neighbours 19.4% 26.5% 
Newspaper 19.4% 24.1% 
Magazines 11.1% 13.2% 
CONCLUSIONS 
 In our study, the ones who knew that HPV 
could be sexually transmitted were 24.5%. When 
the other studies were checked, there were high 
rates like 86% in the study which Giles and others 
carried on
6
, 86.5% in the study of Kahn and 
others
14
, 63% in the study of Tiro and others in 
USA 
15
 and 57% in a study that Hughes and others 
conducted among parents
16
. In our country, the 
rates were 10.8% and  22.6% in the studies that 
was conducted on college students
5,17
. The rates 
of right answers in our study was lower than the 
studies above while it was higher by comparison to 
the outcomes of other studies in our country
5,17
. 
Absence of education about safe sex and sexually 
transmitted diseases in adolescence is seen as a 
significant reason for it. 
 In a study in USA, 39% of the participants 
knew the relation between HPV and cervical 
cancer, 33.8% of them knew that genital warts 
were caused by HPV infections
18
. In the study that 
was carried out in Malaysia, the participants who 
linked HPV with cervical canser were at a rate of  
51.2%
19
. In the other study, the participants who 
concluded that cervical cancer are caused by HPV 
infections were at a rate of 84% and those who 
linked HPV infections with genital warts were at a 
rate of 6%
16
. In a study that was done in Italy; 
23.3% of the participants knew that infection at the 
vaginal mucosa is caused by HPV and cervical 
cancer is associated with HPV infection
20
. In one of 
the studies that were done in our country, while the 
participants who knew HPV-related lesions were at  
 
a rate of 17.2%
5
 , in another study 32.3% of the 
students were able to link HPV with cervical 
cancer
17
. The result that we obtained from our 
study was 21.4%. The value which is close to the 
studies that were conducted in our country is lower 
in comparison with the studies in literature. 
Therefore, it stands out as a different title to focus 
on when training on this topic. 
 The rates for knowledge of  asymptomatic 
HPV infection were 17% and 81% in some 
studies
14,21
. In our study, the rate was 3.7%. More 
people will be able to receive a curative and an 
efficient treatment by being diognased at an early 
period. As the individuals who show risky 
behaviour will not have to wait for a symptom or 
lesion to go to a health care organization for 
necessary screening owing to awareness of 
asymptomatic infection. Thus, it is important that 
the individuals are informed on this point. 
 In our study, another statement that we 
pointed out to the participants was concerning that 
using oral contraceptive prevented from HPV 
transmission. Of the participants, 10.9% indicated 
that this statement was false. On the other hand, in 
the study that was done in Italy the value was 
36.3%
20
. This low rate that was obtained from our 
study is significant in terms of showing that it is 
necessary to inform the people about which oral 
contraceptive does not have a protective effect 
against the sexually transmitted infections. 
 There are different studies related to 
awareness rate of HPV in literature. In two studies 
conducted in Turkey, HPV awareness was found 
21.3% and 24.1% respectively
5,17
. On the other 
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hand, this rate in the studies abroad was between 
the values 8% and 93%
6,15,16,18,20-28
. When the 
countries were checked where the studies were 
conducted, in developed countries in terms of 
socio-economical aspects, high awareness rate 
was clearly observed, which had community 
based-screening programme and where 
vaccination was at high rates. In our study, the 
participants being aware of  HPV infection were 
found as 24.5% and an outcome occured which 
was similar to the previous studies in our 
country
5,17
. In comparison to the various countries 
in the world, awareness rate of HPV was low in 
Turkey. In the current study, level of knowledge, 
frequency of gynecologic examination, the place 
where health care service was offered and to be 
registered for pap-smear significantly affected the 
percentage of HPV awareness (p<0.05). In a 
study, it was observed that level of education, to 
go to medical centres and to be registered for pap-
smear had positive effects on this situation
15,22,23
. 
Apart from our study when literature is reviewed, it 
is understood that university training affected HPV 
awareness in a positive way. That the rise in 
frequency of gynecologic examination increased 
HPV awareness reveals that the examination is an 
opportunity to raise awareness and provide 
education apart from its physical aspect. That the 
rate was higher with the patients who especially 
went to university and private hospitals to get 
healthcare can be related to family planning, the 
presence of healthcare professional  who provide 
education in Gynecology Units as well as enough 
time to take care of patient.  
 In this study, the main source related to HPV 
awareness was  healthcare staff(72.2%). TV and 
internet were subsequent resources. Healthcare 
staff come first or second in literature, too
20,21,24
. 
Although we have a low rate, healthcare staff are 
precious in terms of the correct orientation of 
society when they are meant to be the main 
source. In-service training about this topic will both 
increase the awareness of doctors and enable 
them to check their knowledge.  
 Also, the awareness rate of which HPV 
infection doesn’t occur only in women was 
diagnosed as 9.5%. To change the perception 
about which the infection only occurs in women 
that can be formed due to women oriented 
screening programmes is important in terms of 
keeping the infection under control. 
 In our study 22% of the participants heard 
about HPV vaccine. On the other hand, the 
awareness rate was between 33% and 82% 
6,16,28
. 
When we search the studies that were carried out 
in our country, rates 17.1% , 16.1% and 25.1% 
were obtained 
5,17,29
. However the rate in our study 
is lower in comparison with the results in the world, 
it is at the relative level with the studies of our 
country. That the awareness rate of HPV infections 
is low naturally leads to the low awareness rate of 
HPV vaccine.  
 The most frequent answer given to the 
question “Where did you hear about HPV 
vaccine?” was healthcare staff (53%). TV (50.6%) 
and internet (30.1%) came subsequently. However 
in the studies that were done in our country and 
the other countries healthcare staff did not come 
first
16,17,20
. In the literature, it was diagnosed that 
the most important factor that directed women to 
ask for getting vaccinated for both themselves and 
their daughters was the offer of a doctor 
10,30
. The 
information and offer about vaccination which is 
given by the medical staff have vital importance in 
terms of vaccination acceptance by a great 
majority of the society. 
 This study was carried out in family medicine 
clinics belonged to the biggest teaching and 
research hospital in Ankara thus it covers primary 
care samples from a large geographical area. The 
patients who are illiterate, have troubles in 
communicating and that are visually, hearing or 
physically impaired at high levels to fill out 
questionnaire were not included in our study. 
Therefore, the values we found in our study may 
reflect the numerical values which are higher than 
the society. 
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 Comparative studies that will be carried out by 
different primary care units will provide distinct data 
about knowledge of society and empower need 
assessment studies. 
 As it seen clearly in our study, women who 
applies primary care units has low knowledge 
levels; it is apperent that personal and social 
education is needed. Paying importance to patient 
education on HPV and cervical cancer in primary 
care health politics will increase knowledge and 
awareness for HPV and HPV vaccination. 
 The funding sources and/or granting agencies 
that supported their work, as well as all institutional 
or corporate affiliations of all the authors:None. 
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